OP-5558

N/A

Report date: 2022/05/10 11:44:28
NME

Base Information

Drug NameOP-5558
Drug Alias NameOP5558
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5'-nucleotidase inhibitors
Targets5'-nucleotidase
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOric Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOric Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A